Azilsartan (Edarbi®)

Assessment Status Rapid Review Complete
HTA ID -
Drug Azilsartan
Brand Edarbi®
Indication For the treatment of essential hypertension in adults.
Assessment Process
Rapid review commissioned 10/01/2012
Rapid review completed 11/01/2012
Rapid review outcome Full Pharmacoeconomic Evaluation not Recommended